Altria
Altria Q4 EPS In-Line but Revenue Misses, Where is the Growth?
Tobacco company Altria (NYSE:MO) announced results that exactly met expectations but is still struggling to find growth. Revenue came in…
Cronos Q4 2018 Earnings Review – The New Most Expensive Stock in Cannabis
In Cronos' (TSX: CRON) latest earnings report, they both grabbed the crown for most expensive cannabis company and disappointed with…
Altria Invests $2.4 Billion in Cronos Group
In an effort to develop new product lines and expand large-scale cultivation capabilities, Cronos Group Inc. (NASDAQ: CRON; TSX: CRON) just…
Cronos – No Cash, No Deal….. Tough Times
Bottom Line The leak of acquisition talks between Cronos and Altria is a classic tactic used by companies to support…
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (October 13, 2018)
Altria has Aphria in Their Crosshairs Bottom Line: Deal chatter will continue to support the cannabis sector over the next 12…
Altria has Aphria in their Crosshairs – What a Deal Would Mean for the Cannabis Industry
Altria in Talks with Aphria The Globe and Mail put out an article (Paywall) today saying that Aphria (Ticker: APH.TO)…